PACS — PACS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapSuper Stock

Annual income statement for PACS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,167	2,422	3,111	4,090	5,289
Cost of Revenue
Gross Profit	265	561	664	793	1,159
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,083	2,193	2,904	3,959	4,979
Operating Profit	83.4	229	208	131	310
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	81.4	207	157	102	284
Provision for Income Taxes
Net Income After Taxes	47.9	150	113	55.3	191
Minority Interest
Net Income Before Extraordinary Items
Net Income	47.9	150	113	55.8	192
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	47.9	150	113	55.8	192
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.324	1.02	0.764	0.278	1.58